VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by mtvrdonon Mar 06, 2017 10:17am

49 Views

Post# 25936581

RE:RE:RE:RE:RE:RE:Just chill and wait for it .

I think there is a pretty safe base at around 40 cents. There is definitely value in the product and insiders and larger investors hold lots of the shares. The 40 cent warrants are something that all those insiders and large holder will want to support.

I think it will trade in the 40 to 60 cent range at least. There were millions of shares (most of the float) that traded over 60 last week. They are also a couple months into their new marketing campaign. There is probably also some news fairly soon about China (both an update on production and perhaps an update on how sales/marketing in that market are going).

I think it should do well from these prices.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale